{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:18:36Z","timestamp":1791199116571,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Antibiotic combination therapy for <jats:italic>Helicobacter pylori<\/jats:italic> eradication must be adapted to local resistance patterns, but the epidemiology of <jats:italic>H. pylori<\/jats:italic> resistance to antibiotics is poorly documented in Africa. The aim was to determine the antibiotic resistance rates, as well as the associated molecular mechanisms, of strains isolated in Dakar, Senegal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred and eight <jats:italic>H. pylori<\/jats:italic> strains were isolated between 2007 and 2009 from 108 patients presenting with upper abdominal pain to the Gastroenterology Department of Le Dantec Hospital. Antimicrobial susceptibility testing was performed for amoxicillin, clarithromycin, metronidazole, levofloxacin and tetracyclin using the E-test method. Mutations in the 23S rRNA gene of clarithromycin-resistant strains and in <jats:italic>gyrA<\/jats:italic> and <jats:italic>gyrB<\/jats:italic> of levofloxacin-resistant strains were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Isolates were characterized by no resistance to amoxicillin (0%), tetracycline (0%), and very low rate of resistance to clarithromycin (1%), but a high rate of resistance to metronidazole (85%). The clarithromycin-resistant strain displayed the A2143G mutation. A worrying rate of levofloxacin resistance was detected (15%). N87I and D91N were the most common mutations in the quinolone-resistance-determining region of <jats:italic>gyrA<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The first-line empirical regimen for <jats:italic>H. pylori<\/jats:italic> eradication in Senegal should include clarithromycin. Increasing rates of fluoroquinolone resistance detected should discourage the use of levofloxacin-containing regimens without prior antimicrobial susceptibility testing.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-0711-12-3","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T16:21:33Z","timestamp":1357748493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Abdoulaye","family":"Seck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Burucoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daouda","family":"Dia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhamadou","family":"Mbengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuella","family":"Onambele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josette","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Breurec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"274_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991, 325: 1127-1131. 10.1056\/NEJM199110173251603","journal-title":"N Engl J Med"},{"key":"274_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ: Management of Helicobacter pylori infection\u2013the Maastricht IV\/ Florence Consensus Report. Gut. 2012, 61: 646-664. 10.1136\/gutjnl-2012-302084","journal-title":"Gut"},{"key":"274_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/gut.2007.132514","volume":"56","author":"F Megraud","year":"2007","unstructured":"Megraud F: Helicobacter pylori and antibiotic resistance. Gut. 2007, 56: 1502- 10.1136\/gut.2007.132514","journal-title":"Gut"},{"key":"274_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/AAC.05243-11","volume":"56","author":"M Garcia","year":"2012","unstructured":"Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C: Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother. 2012, 56: 550-551. 10.1128\/AAC.05243-11","journal-title":"Antimicrob Agents Chemother"},{"key":"274_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-230X-3-20","volume":"3","author":"AP Godoy","year":"2003","unstructured":"Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, Pedrazzoli J: Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol. 2003, 3: 20- 10.1186\/1471-230X-3-20","journal-title":"BMC Gastroenterol"},{"key":"274_CR6","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/JCM.42.10.4856-4858.2004","volume":"42","author":"S Nahar","year":"2004","unstructured":"Nahar S, Mukhopadhyay AK, Khan R, Ahmad MM, Datta S, Chattopadhyay S, Dhar SC, Sarker SA, Engstrand L, Berg DE, Nair GB, Rahman M: Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol. 2004, 42: 4856-4858. 10.1128\/JCM.42.10.4856-4858.2004","journal-title":"J Clin Microbiol"},{"key":"274_CR7","first-page":"143","volume":"7","author":"OA Aboderin","year":"2007","unstructured":"Aboderin OA, Abdu AR, Odetoyin B, Okeke IN, Lawal OO, Ndububa DA, Agbakwuru AE, Lamikanra A: Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria. Afr Health Sci. 2007, 7: 143-147.","journal-title":"Afr Health Sci"},{"key":"274_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3855\/jidc.512","volume":"3","author":"A Seck","year":"2009","unstructured":"Seck A, Mbengue M, Gassama-Sow A, Diouf L, Ka MM, Boye CS: Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. J Infect Dev Ctries. 2009, 3: 137-140.","journal-title":"J Infect Dev Ctries"},{"key":"274_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1365-3156.2008.02062.x","volume":"13","author":"RN Ndip","year":"2008","unstructured":"Ndip RN, Malange Takang AE, Ojongokpoko JE, Luma HN, Malongue A, Akoachere JF, Ndip LM, MacMillan M, Weaver LT: Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop Med Int Health. 2008, 13: 848-854. 10.1111\/j.1365-3156.2008.02062.x","journal-title":"Trop Med Int Health"},{"key":"274_CR10","first-page":"52","volume":"83","author":"AB Price","year":"1999","unstructured":"Price AB: Classification of gastritis\u2013yesterday, today and tomorrow. Verhandlungen der Deutschen Gesellschaft fur Pathologie. 1999, 83: 52-55.","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Pathologie"},{"key":"274_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M: The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000, 47: 251-255. 10.1136\/gut.47.2.251","journal-title":"Gut"},{"key":"274_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-0711-9-22","volume":"9","author":"K Ben Mansour","year":"2010","unstructured":"Ben Mansour K, Burucoa C, Zribi M, Masmoudi A, Karoui S, Kallel L, Chouaib S, Matri S, Fekih M, Zarrouk S, Labbene M, Boubaker J, Cheikh I, Hriz MB, Siala N, Ayadi A, Filali A, Mami NB, Najjar T, Maherzi A, Sfar MT, Fendri C: Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob. 2010, 9: 22- 10.1186\/1476-0711-9-22","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"274_CR13","first-page":"M100-S22","volume-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute: CLSI document. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. 2012, M100-S22-Wayne, PA: Clinical and Laboratory Standards Institute,"},{"key":"274_CR14","volume-title":"EUCAST Disk diffusion manual","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2012","unstructured":"European Committee on Antimicrobial Susceptibility Testing: EUCAST Disk diffusion manual. 2012, http:\/\/www.eucast.org\/eucast_susceptibility_testing\/disk_diffusion_methodology."},{"key":"274_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/AAC.00614-06","volume":"51","author":"E Glocker","year":"2007","unstructured":"Glocker E, Stueger HP, Kist M: Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother. 2007, 51: 346-349. 10.1128\/AAC.00614-06","journal-title":"Antimicrob Agents Chemother"},{"key":"274_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1523-5378.2009.00655.x","volume":"14","author":"KH Hung","year":"2009","unstructured":"Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, Wu JJ: Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter. 2009, 14: 61-65. 10.1111\/j.1523-5378.2009.00655.x","journal-title":"Helicobacter"},{"key":"274_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/jac\/dki334","volume":"56","author":"JM Kim","year":"2005","unstructured":"Kim JM, Kim JS, Kim N, Jung HC, Song IS: Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother. 2005, 56: 965-967. 10.1093\/jac\/dki334","journal-title":"J Antimicrob Chemother"},{"key":"274_CR18","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/AAC.47.12.3942-3944.2003","volume":"47","author":"J Tankovic","year":"2003","unstructured":"Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ: Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003, 47: 3942-3944. 10.1128\/AAC.47.12.3942-3944.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"274_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","volume":"29","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E: Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents. 2007, 29: 389-396. 10.1016\/j.ijantimicag.2006.11.007","journal-title":"Int J Antimicrob Agents"},{"key":"274_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jac\/dkr410","volume":"67","author":"A Cuadrado-Lavin","year":"2012","unstructured":"Cuadrado-Lavin A, Salcines-Caviedes JR, Carrascosa MF, Mellado P, Monteagudo I, Llorca J, Cobo M, Campos MR, Ayestaran B, Fernandez-Pousa A, Gonzalez-Colominas E: Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. J Antimicrob Chemother. 2012, 67: 170-173. 10.1093\/jac\/dkr410","journal-title":"J Antimicrob Chemother"},{"key":"274_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/eri.09.113","volume":"8","author":"L Boyanova","year":"2010","unstructured":"Boyanova L, Mitov I: Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther. 2010, 8: 59-70. 10.1586\/eri.09.113","journal-title":"Expert Rev Anti Infect Ther"},{"key":"274_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3855\/jidc.362","volume":"1","author":"JM Sire","year":"2007","unstructured":"Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B: Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries. 2007, 1: 263-268.","journal-title":"J Infect Dev Ctries"},{"key":"274_CR23","first-page":"409","volume":"19","author":"V De Francesco","year":"2010","unstructured":"De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, Ierardi E, Zullo A: Worldwide Helicobacter pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010, 19: 409-414.","journal-title":"J Gastrointestin Liver Dis"},{"key":"274_CR24","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1128\/JCM.42.10.4832-4834.2004","volume":"42","author":"M Sherif","year":"2004","unstructured":"Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW: Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol. 2004, 42: 4832-4834. 10.1128\/JCM.42.10.4832-4834.2004","journal-title":"J Clin Microbiol"},{"key":"274_CR25","first-page":"79","volume":"42","author":"D Asrat","year":"2004","unstructured":"Asrat D, Kassa E, Mengistu Y, Nilsson I, Wadstrom T: Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2004, 42: 79-85.","journal-title":"Ethiop Med J"},{"key":"274_CR26","volume-title":"Gastroenterol Res Pract","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP: Rescue Therapy for Helicobacter pylori Infection 2012. Gastroenterol Res Pract. 2012, in press,"},{"key":"274_CR27","volume-title":"Lancet","author":"JM Liou","year":"2012","unstructured":"Liou JM, Chen CC, Chen MJ, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS: Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2012, in press,"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-0711-12-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:33:09Z","timestamp":1630531989000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/1476-0711-12-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/1476-0711-12-3","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]},"assertion":[{"value":"27 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}